| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Vireo Growth Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.47 |
| 52 Week High | CA$0.68 |
| 52 Week Low | CA$0.09 |
| Beta | 1.42 |
| 11 Month Change | 14.34% |
| 3 Month Change | 21.45% |
| 1 Year Change | 214.63% |
| 33 Year Change | -72.47% |
| 5 Year Change | -78.36% |
| Change since IPO | -89.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| VREO.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 9.0% | 0.2% | 0.02% |
| 1Y | 214.6% | 25.9% | 20.5% |
Return vs Industry: VREO.F exceeded the US Pharmaceuticals industry which returned 25.9% over the past year.
Return vs Market: VREO.F exceeded the US Market which returned 20.5% over the past year.
Price Volatility
| VREO.F volatility | |
|---|---|
| VREO.F Average Weekly Movement | 16.1% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: VREO.F's share price has been volatile over the past 3 months.
Volatility Over Time: VREO.F's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 438 | Josh Rosen | vireohealth.com |
Vireo Growth Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
Vireo Growth Inc. Fundamentals Summary
| VREO.F fundamental statistics | |
|---|---|
| Market cap | US$69.61m |
| Earnings (TTM) | -US$23.85m |
| Revenue (TTM) | US$93.13m |
0.8x
P/S Ratio-3.1x
P/E RatioIs VREO.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VREO.F income statement (TTM) | |
|---|---|
| Revenue | US$93.13m |
| Cost of Revenue | US$46.30m |
| Gross Profit | US$46.83m |
| Other Expenses | US$70.68m |
| Earnings | -US$23.85m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 50.28% |
| Net Profit Margin | -25.61% |
| Debt/Equity Ratio | -311.4% |
How did VREO.F perform over the long term?
See historical performance and comparison